Therefore, in the future, more genetically modified mice, such as microglia-specific Notch-activated mice (CX3CR1-Cre or TMEM119-Cre combined with NICD stop-flox), should be used to clarify the importance of Notch signaling in regulating microglial activation in PD progression. The gene discussed is CX3CR1; the disease is Parkinson disease.